ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,02%
Bitcoin
63 956,85
-0,82%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Nighthawk Biosciences Inc (NHWK)

  7. Nighthawk Biosciences Inc (NHWK) Actualités

NHWK Nighthawk Biosciences Inc

0,4135
0,00 (0,00%)
Après les heures de négociation
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Nighthawk Biosciences Inc NHWK AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,4135 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,4135 0,4135
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202423:00EDGAR2Form 8-K - Current report
01/4/202422:52EDGAR2Form NT 10-K - Notification of inability to timely file Form..
19/3/202413:30GLOBEScorpius Holdings Awarded Contract in Excess of $1 Million..
14/3/202413:30GLOBEScorpius Holdings Accepted as a Member of the US..
13/3/202411:17EDGAR2Form 8-A12B/A - Registration of securities [Section 12(b)]:..
13/3/202411:01EDGAR2Form 8-K - Current report
12/3/202422:00GLOBEScorpius Holdings, Inc. Announces Closing of Public Offering
08/3/202406:20GLOBEScorpius Holdings, Inc. Announces Pricing of Public Offering
07/3/202422:18GLOBEScorpius Holdings, Inc. Announces Proposed Public Offering..
07/3/202414:30GLOBEScorpius Holdings Estimates Greater than 375% Sequential..
06/2/202415:34EDGAR2Form 8-K - Current report
06/2/202414:00GLOBENightHawk Biosciences Completes Name Change to Scorpius..
01/2/202414:00GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Announces..
30/1/202414:00EDGAR2Form 8-K - Current report
30/1/202414:00GLOBENightHawk Receives Proceeds of $3.25 Million in Connection..
26/1/202422:30EDGAR2Form 8-K - Current report
25/1/202414:30GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Awarded..
22/1/202414:00EDGAR2Form 8-K - Current report
16/1/202414:30EDGAR2Form 8-K - Current report
16/1/202414:30GLOBENightHawk’s Scorpius BioManufacturing Subsidiary Commences..
11/1/202422:59EDGAR2Form 8-K - Current report
08/1/202414:30EDGAR2Form 8-K - Current report
08/1/202414:30GLOBENightHawk Biosciences Announces Planned Name Change to..
03/1/202414:30GLOBENightHawk Biosciences Commences Work on Multi-Million-Dollar..
27/12/202322:57EDGAR2Form 8-K - Current report
21/12/202314:30GLOBENightHawk Biosciences Announces Completion of Demonstration..
19/12/202322:47EDGAR2Form S-3 - Registration statement under Securities Act of..
19/12/202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/12/202322:05EDGAR2Form 8-K - Current report
18/12/202314:30GLOBENightHawk Biosciences Announces Major Milestone with..
12/12/202322:03EDGAR2Form 8-K - Current report
12/12/202314:30GLOBENightHawk Biosciences Announces Strategic Shift into a..
08/12/202322:31EDGAR2Form 8-K - Current report
08/12/202322:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/11/202322:05GLOBENightHawk Biosciences Provides Q3 2023 Business Update
14/8/202322:05GLOBENightHawk Biosciences Provides Q2 2023 Business Update
15/5/202322:05GLOBENightHawk Biosciences Provides Q1 2023 Business Update

Dernières Valeurs Consultées

AMEX
NHWK
Nighthawk Biosciences
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés